Literature DB >> 25289370

New Developments in Understanding and Treating Adolescent Marijuana Dependence.

Kevin M Gray.   

Abstract

BACKGROUND: Marijuana is the most commonly used illicit substance in the United States and worldwide. Marijuana use is a problem of increasing magnitude among adolescents. Use typically begins in adolescence and is associated with a variety of adverse outcomes.
METHOD: This article will present an overview of trends in marijuana use, and will review the endocannabinoid system and marijuana. It will discuss recent policy developments in US and their implications, especially for adolescents. Existing treatments will be reviewed, including findings from a recent randomized double-blind trial of N-acetylcysteine, a compound that reverses the dysregulation of the glutamate system that occurs in substance dependence.
CONCLUSIONS: The core treatment approaches include psychosocial interventions, sometimes in combination with each other. While a reduction in days of use is often achieved with most of these approaches, abstinence is a much more elusive goal. The evidence base for effective treatments remains inadequate especially with regard to adolescents, and there is an urgent need for more research in this area. Promising new treatments include N-acetylcysteine in conjunction with contingency management.

Entities:  

Keywords:  Adolescents; N-acetylcysteine; cannabis dependence; marijuana dependence; marijuana use disorders; treatment

Year:  2013        PMID: 25289370      PMCID: PMC4185187          DOI: 10.2174/221067660304140121173215

Source DB:  PubMed          Journal:  Adolesc Psychiatry (Hilversum)        ISSN: 2210-6766


  37 in total

1.  Cannabis use and psychosocial adjustment in adolescence and young adulthood.

Authors:  David M Fergusson; L John Horwood; Nicola Swain-Campbell
Journal:  Addiction       Date:  2002-09       Impact factor: 6.526

2.  Early-onset cannabis use and cognitive deficits: what is the nature of the association?

Authors:  Harrison G Pope; Amanda J Gruber; James I Hudson; Geoffrey Cohane; Marilyn A Huestis; Deborah Yurgelun-Todd
Journal:  Drug Alcohol Depend       Date:  2003-04-01       Impact factor: 4.492

Review 3.  Evidence-based psychosocial treatments for adolescent substance abuse.

Authors:  Holly Barrett Waldron; Charles W Turner
Journal:  J Clin Child Adolesc Psychol       Date:  2008-01

4.  Persistent cannabis users show neuropsychological decline from childhood to midlife.

Authors:  Madeline H Meier; Avshalom Caspi; Antony Ambler; HonaLee Harrington; Renate Houts; Richard S E Keefe; Kay McDonald; Aimee Ward; Richie Poulton; Terrie E Moffitt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-27       Impact factor: 11.205

5.  A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults.

Authors:  Barbara J Mason; Rebecca Crean; Vivian Goodell; John M Light; Susan Quello; Farhad Shadan; Kimberly Buffkins; Mark Kyle; Murali Adusumalli; Adnan Begovic; Santosh Rao
Journal:  Neuropsychopharmacology       Date:  2012-02-29       Impact factor: 7.853

6.  Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse.

Authors:  Margaret Haney; Carl L Hart; Suzanne K Vosburg; Sandra D Comer; Stephanie Collins Reed; Ziva D Cooper; Richard W Foltin
Journal:  Psychopharmacology (Berl)       Date:  2010-06-03       Impact factor: 4.530

7.  Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking.

Authors:  Megan M Moran; Krista McFarland; Roberto I Melendez; Peter W Kalivas; Jeremy K Seamans
Journal:  J Neurosci       Date:  2005-07-06       Impact factor: 6.167

Review 8.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Authors:  Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis
Journal:  Lancet       Date:  2007-07-28       Impact factor: 79.321

9.  Blunted cystine-glutamate antiporter function in the nucleus accumbens promotes cocaine-induced drug seeking.

Authors:  K S Kau; A Madayag; J R Mantsch; M D Grier; O Abdulhameed; D A Baker
Journal:  Neuroscience       Date:  2008-06-10       Impact factor: 3.590

Review 10.  Glutamatergic substrates of drug addiction and alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  Biochem Pharmacol       Date:  2007-06-30       Impact factor: 5.858

View more
  4 in total

1.  A Phone Consultation Call Line to Support SBIRT in Pediatric Primary Care.

Authors:  Sharon Levy; Alyssa Fuller; Shawn Kelly; Julie Lunstead; Elissa R Weitzman; John H Straus
Journal:  Front Psychiatry       Date:  2022-05-11       Impact factor: 5.435

2.  Adolescent Δ(9)-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats.

Authors:  Maria Scherma; Christian Dessì; Anna Lisa Muntoni; Salvatore Lecca; Valentina Satta; Antonio Luchicchi; Marco Pistis; Leigh V Panlilio; Liana Fattore; Steven R Goldberg; Walter Fratta; Paola Fadda
Journal:  Neuropsychopharmacology       Date:  2015-09-21       Impact factor: 7.853

3.  Identifying adolescent protective factors that disrupt the intergenerational transmission of cannabis use and disorder.

Authors:  W Andrew Rothenberg; Ariel Sternberg; Austin Blake; Jack Waddell; Laurie Chassin; Andrea Hussong
Journal:  Psychol Addict Behav       Date:  2019-09-16

4.  End User-Informed Mobile Health Intervention Development for Adolescent Cannabis Use Disorder: Qualitative Study.

Authors:  Kara Bagot; Elizabeth Hodgdon; Natasha Sidhu; Kevin Patrick; Mikaela Kelly; Yang Lu; Eraka Bath
Journal:  JMIR Mhealth Uhealth       Date:  2019-10-04       Impact factor: 4.773

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.